The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Obesity Treating Neuromodulation System Market Research Report 2025

Global Obesity Treating Neuromodulation System Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1933882

No of Pages : 82

Ask Your Query

Synopsis

Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.

The global Obesity Treating Neuromodulation System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.

This report aims to provide a comprehensive presentation of the global market for Obesity Treating Neuromodulation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treating Neuromodulation System.

Report Scope

The Obesity Treating Neuromodulation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Obesity Treating Neuromodulation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Obesity Treating Neuromodulation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Medtronic
  • Cyberonics
  • Abbott
  • BioControl Medical
  • Leptos Medical
  • ReShape Lifesciences
  • Nevro
  • Nuvectra

Segment by Type

  • Vagus Nerve Stimulator
  • Splanchnic Nerve Stimulator
  • Deep Brain Stimulator
  • Spinal Cord Stimulator
  • Autonomous Nerve Stimulator
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Obesity Treating Neuromodulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Obesity Treating Neuromodulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Obesity Treating Neuromodulation System Market Overview
1.1 Product Overview and Scope of Obesity Treating Neuromodulation System
1.2 Obesity Treating Neuromodulation System Segment by Type
1.2.1 Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2024-2030)
1.2.2 Vagus Nerve Stimulator
1.2.3 Splanchnic Nerve Stimulator
1.2.4 Deep Brain Stimulator
1.2.5 Spinal Cord Stimulator
1.2.6 Autonomous Nerve Stimulator
1.2.7 Others
1.3 Obesity Treating Neuromodulation System Segment by Application
1.3.1 Global Obesity Treating Neuromodulation System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Obesity Treating Neuromodulation System Market Size Estimates and Forecasts
1.4.1 Global Obesity Treating Neuromodulation System Revenue 2019-2030
1.4.2 Global Obesity Treating Neuromodulation System Sales 2019-2030
1.4.3 Global Obesity Treating Neuromodulation System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Obesity Treating Neuromodulation System Market Competition by Manufacturers
2.1 Global Obesity Treating Neuromodulation System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Obesity Treating Neuromodulation System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Obesity Treating Neuromodulation System Average Price by Manufacturers (2019-2024)
2.4 Global Obesity Treating Neuromodulation System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Obesity Treating Neuromodulation System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Obesity Treating Neuromodulation System, Product Type & Application
2.7 Obesity Treating Neuromodulation System Market Competitive Situation and Trends
2.7.1 Obesity Treating Neuromodulation System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Obesity Treating Neuromodulation System Players Market Share by Revenue
2.7.3 Global Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Obesity Treating Neuromodulation System Retrospective Market Scenario by Region
3.1 Global Obesity Treating Neuromodulation System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Obesity Treating Neuromodulation System Global Obesity Treating Neuromodulation System Sales by Region: 2019-2030
3.2.1 Global Obesity Treating Neuromodulation System Sales by Region: 2019-2024
3.2.2 Global Obesity Treating Neuromodulation System Sales by Region: 2025-2030
3.3 Global Obesity Treating Neuromodulation System Global Obesity Treating Neuromodulation System Revenue by Region: 2019-2030
3.3.1 Global Obesity Treating Neuromodulation System Revenue by Region: 2019-2024
3.3.2 Global Obesity Treating Neuromodulation System Revenue by Region: 2025-2030
3.4 North America Obesity Treating Neuromodulation System Market Facts & Figures by Country
3.4.1 North America Obesity Treating Neuromodulation System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Obesity Treating Neuromodulation System Sales by Country (2019-2030)
3.4.3 North America Obesity Treating Neuromodulation System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Obesity Treating Neuromodulation System Market Facts & Figures by Country
3.5.1 Europe Obesity Treating Neuromodulation System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Obesity Treating Neuromodulation System Sales by Country (2019-2030)
3.5.3 Europe Obesity Treating Neuromodulation System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Obesity Treating Neuromodulation System Market Facts & Figures by Country
3.6.1 Asia Pacific Obesity Treating Neuromodulation System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Obesity Treating Neuromodulation System Sales by Country (2019-2030)
3.6.3 Asia Pacific Obesity Treating Neuromodulation System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Obesity Treating Neuromodulation System Market Facts & Figures by Country
3.7.1 Latin America Obesity Treating Neuromodulation System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Obesity Treating Neuromodulation System Sales by Country (2019-2030)
3.7.3 Latin America Obesity Treating Neuromodulation System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Obesity Treating Neuromodulation System Market Facts & Figures by Country
3.8.1 Middle East and Africa Obesity Treating Neuromodulation System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Obesity Treating Neuromodulation System Sales by Type (2019-2030)
4.1.1 Global Obesity Treating Neuromodulation System Sales by Type (2019-2024)
4.1.2 Global Obesity Treating Neuromodulation System Sales by Type (2025-2030)
4.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Type (2019-2030)
4.2 Global Obesity Treating Neuromodulation System Revenue by Type (2019-2030)
4.2.1 Global Obesity Treating Neuromodulation System Revenue by Type (2019-2024)
4.2.2 Global Obesity Treating Neuromodulation System Revenue by Type (2025-2030)
4.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2019-2030)
4.3 Global Obesity Treating Neuromodulation System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Obesity Treating Neuromodulation System Sales by Application (2019-2030)
5.1.1 Global Obesity Treating Neuromodulation System Sales by Application (2019-2024)
5.1.2 Global Obesity Treating Neuromodulation System Sales by Application (2025-2030)
5.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Application (2019-2030)
5.2 Global Obesity Treating Neuromodulation System Revenue by Application (2019-2030)
5.2.1 Global Obesity Treating Neuromodulation System Revenue by Application (2019-2024)
5.2.2 Global Obesity Treating Neuromodulation System Revenue by Application (2025-2030)
5.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2019-2030)
5.3 Global Obesity Treating Neuromodulation System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Obesity Treating Neuromodulation System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Cyberonics
6.2.1 Cyberonics Corporation Information
6.2.2 Cyberonics Description and Business Overview
6.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cyberonics Obesity Treating Neuromodulation System Product Portfolio
6.2.5 Cyberonics Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Obesity Treating Neuromodulation System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 BioControl Medical
6.4.1 BioControl Medical Corporation Information
6.4.2 BioControl Medical Description and Business Overview
6.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioControl Medical Obesity Treating Neuromodulation System Product Portfolio
6.4.5 BioControl Medical Recent Developments/Updates
6.5 Leptos Medical
6.5.1 Leptos Medical Corporation Information
6.5.2 Leptos Medical Description and Business Overview
6.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leptos Medical Obesity Treating Neuromodulation System Product Portfolio
6.5.5 Leptos Medical Recent Developments/Updates
6.6 ReShape Lifesciences
6.6.1 ReShape Lifesciences Corporation Information
6.6.2 ReShape Lifesciences Description and Business Overview
6.6.3 ReShape Lifesciences Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ReShape Lifesciences Obesity Treating Neuromodulation System Product Portfolio
6.6.5 ReShape Lifesciences Recent Developments/Updates
6.7 Nevro
6.6.1 Nevro Corporation Information
6.6.2 Nevro Description and Business Overview
6.6.3 Nevro Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nevro Obesity Treating Neuromodulation System Product Portfolio
6.7.5 Nevro Recent Developments/Updates
6.8 Nuvectra
6.8.1 Nuvectra Corporation Information
6.8.2 Nuvectra Description and Business Overview
6.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nuvectra Obesity Treating Neuromodulation System Product Portfolio
6.8.5 Nuvectra Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Obesity Treating Neuromodulation System Industry Chain Analysis
7.2 Obesity Treating Neuromodulation System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Obesity Treating Neuromodulation System Production Mode & Process
7.4 Obesity Treating Neuromodulation System Sales and Marketing
7.4.1 Obesity Treating Neuromodulation System Sales Channels
7.4.2 Obesity Treating Neuromodulation System Distributors
7.5 Obesity Treating Neuromodulation System Customers
8 Obesity Treating Neuromodulation System Market Dynamics
8.1 Obesity Treating Neuromodulation System Industry Trends
8.2 Obesity Treating Neuromodulation System Market Drivers
8.3 Obesity Treating Neuromodulation System Market Challenges
8.4 Obesity Treating Neuromodulation System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Obesity Treating Neuromodulation System Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Obesity Treating Neuromodulation System Market Competitive Situation by Manufacturers in 2023
Table 4. Global Obesity Treating Neuromodulation System Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Obesity Treating Neuromodulation System Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Obesity Treating Neuromodulation System Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Obesity Treating Neuromodulation System, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Obesity Treating Neuromodulation System, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Obesity Treating Neuromodulation System, Product Type & Application
Table 12. Global Key Manufacturers of Obesity Treating Neuromodulation System, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Obesity Treating Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treating Neuromodulation System as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Obesity Treating Neuromodulation System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Obesity Treating Neuromodulation System Sales by Region (2019-2024) & (K Units)
Table 18. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2019-2024)
Table 19. Global Obesity Treating Neuromodulation System Sales by Region (2025-2030) & (K Units)
Table 20. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2025-2030)
Table 21. Global Obesity Treating Neuromodulation System Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2019-2024)
Table 23. Global Obesity Treating Neuromodulation System Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2025-2030)
Table 25. North America Obesity Treating Neuromodulation System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Obesity Treating Neuromodulation System Sales by Country (2019-2024) & (K Units)
Table 27. North America Obesity Treating Neuromodulation System Sales by Country (2025-2030) & (K Units)
Table 28. North America Obesity Treating Neuromodulation System Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Obesity Treating Neuromodulation System Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Obesity Treating Neuromodulation System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Obesity Treating Neuromodulation System Sales by Country (2019-2024) & (K Units)
Table 32. Europe Obesity Treating Neuromodulation System Sales by Country (2025-2030) & (K Units)
Table 33. Europe Obesity Treating Neuromodulation System Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Obesity Treating Neuromodulation System Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Obesity Treating Neuromodulation System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Obesity Treating Neuromodulation System Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Obesity Treating Neuromodulation System Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Obesity Treating Neuromodulation System Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Obesity Treating Neuromodulation System Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Obesity Treating Neuromodulation System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Obesity Treating Neuromodulation System Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Obesity Treating Neuromodulation System Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Obesity Treating Neuromodulation System Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Obesity Treating Neuromodulation System Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Obesity Treating Neuromodulation System Sales (K Units) by Type (2019-2024)
Table 51. Global Obesity Treating Neuromodulation System Sales (K Units) by Type (2025-2030)
Table 52. Global Obesity Treating Neuromodulation System Sales Market Share by Type (2019-2024)
Table 53. Global Obesity Treating Neuromodulation System Sales Market Share by Type (2025-2030)
Table 54. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2019-2024)
Table 57. Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2025-2030)
Table 58. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2019-2024)
Table 59. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2025-2030)
Table 60. Global Obesity Treating Neuromodulation System Sales (K Units) by Application (2019-2024)
Table 61. Global Obesity Treating Neuromodulation System Sales (K Units) by Application (2025-2030)
Table 62. Global Obesity Treating Neuromodulation System Sales Market Share by Application (2019-2024)
Table 63. Global Obesity Treating Neuromodulation System Sales Market Share by Application (2025-2030)
Table 64. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2019-2024)
Table 67. Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2025-2030)
Table 68. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2019-2024)
Table 69. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2025-2030)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Medtronic Obesity Treating Neuromodulation System Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Cyberonics Corporation Information
Table 76. Cyberonics Description and Business Overview
Table 77. Cyberonics Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Cyberonics Obesity Treating Neuromodulation System Product
Table 79. Cyberonics Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Obesity Treating Neuromodulation System Product
Table 84. Abbott Recent Developments/Updates
Table 85. BioControl Medical Corporation Information
Table 86. BioControl Medical Description and Business Overview
Table 87. BioControl Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. BioControl Medical Obesity Treating Neuromodulation System Product
Table 89. BioControl Medical Recent Developments/Updates
Table 90. Leptos Medical Corporation Information
Table 91. Leptos Medical Description and Business Overview
Table 92. Leptos Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Leptos Medical Obesity Treating Neuromodulation System Product
Table 94. Leptos Medical Recent Developments/Updates
Table 95. ReShape Lifesciences Corporation Information
Table 96. ReShape Lifesciences Description and Business Overview
Table 97. ReShape Lifesciences Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. ReShape Lifesciences Obesity Treating Neuromodulation System Product
Table 99. ReShape Lifesciences Recent Developments/Updates
Table 100. Nevro Corporation Information
Table 101. Nevro Description and Business Overview
Table 102. Nevro Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Nevro Obesity Treating Neuromodulation System Product
Table 104. Nevro Recent Developments/Updates
Table 105. Nuvectra Corporation Information
Table 106. Nuvectra Description and Business Overview
Table 107. Nuvectra Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Nuvectra Obesity Treating Neuromodulation System Product
Table 109. Nuvectra Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Obesity Treating Neuromodulation System Distributors List
Table 113. Obesity Treating Neuromodulation System Customers List
Table 114. Obesity Treating Neuromodulation System Market Trends
Table 115. Obesity Treating Neuromodulation System Market Drivers
Table 116. Obesity Treating Neuromodulation System Market Challenges
Table 117. Obesity Treating Neuromodulation System Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Obesity Treating Neuromodulation System
Figure 2. Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Obesity Treating Neuromodulation System Market Share by Type in 2023 & 2030
Figure 4. Vagus Nerve Stimulator Product Picture
Figure 5. Splanchnic Nerve Stimulator Product Picture
Figure 6. Deep Brain Stimulator Product Picture
Figure 7. Spinal Cord Stimulator Product Picture
Figure 8. Autonomous Nerve Stimulator Product Picture
Figure 9. Others Product Picture
Figure 10. Global Obesity Treating Neuromodulation System Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Obesity Treating Neuromodulation System Market Share by Application in 2023 & 2030
Figure 12. Hospitals
Figure 13. Clinics
Figure 14. Ambulatory Surgical Centers
Figure 15. Global Obesity Treating Neuromodulation System Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Obesity Treating Neuromodulation System Market Size (2019-2030) & (US$ Million)
Figure 17. Global Obesity Treating Neuromodulation System Sales (2019-2030) & (K Units)
Figure 18. Global Obesity Treating Neuromodulation System Average Price (USD/Unit) & (2019-2030)
Figure 19. Obesity Treating Neuromodulation System Report Years Considered
Figure 20. Obesity Treating Neuromodulation System Sales Share by Manufacturers in 2023
Figure 21. Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Obesity Treating Neuromodulation System Players: Market Share by Revenue in 2023
Figure 23. Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Obesity Treating Neuromodulation System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Obesity Treating Neuromodulation System Sales Market Share by Country (2019-2030)
Figure 26. North America Obesity Treating Neuromodulation System Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Obesity Treating Neuromodulation System Sales Market Share by Country (2019-2030)
Figure 30. Europe Obesity Treating Neuromodulation System Revenue Market Share by Country (2019-2030)
Figure 31. Germany Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Region (2019-2030)
Figure 38. China Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Obesity Treating Neuromodulation System Sales Market Share by Country (2019-2030)
Figure 49. Latin America Obesity Treating Neuromodulation System Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Obesity Treating Neuromodulation System Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Obesity Treating Neuromodulation System Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Obesity Treating Neuromodulation System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Obesity Treating Neuromodulation System by Type (2019-2030)
Figure 59. Global Revenue Market Share of Obesity Treating Neuromodulation System by Type (2019-2030)
Figure 60. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Obesity Treating Neuromodulation System by Application (2019-2030)
Figure 62. Global Revenue Market Share of Obesity Treating Neuromodulation System by Application (2019-2030)
Figure 63. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2019-2030)
Figure 64. Obesity Treating Neuromodulation System Value Chain
Figure 65. Obesity Treating Neuromodulation System Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock